• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

982
82
61
58
47

COUNTRY

56
19
10
6
5

CATEGORIES

  • 82
  • 120
  • 66
  • 66
  • 36
  • 37
  • 11
  • 11
  • 12
  • 18

PRICE

550
813
1,866
2,623

PUBLISHED

8
255
693
2,623

PRODUCT TYPE

2,472
76
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013

Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Hodgkin Lymphoma - Pipeline Review, H2 2013

Hodgkin Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Hodgkin Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

Peritoneal Cancer - Pipeline Review, H2 2013

Peritoneal Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Peritoneal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

T-Cell Leukemia - Pipeline Review, H2 2013

T-Cell Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'T-Cell Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

July 2013
FROM

Renal Insufficiency - Pipeline Review, H2 2013

Renal Insufficiency - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Renal Insufficiency - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Medullary Thyroid Cancer - Pipeline Review, H2 2013

Medullary Thyroid Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Medullary Thyroid Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Colon Cancer - Pipeline Review, H2 2013

Colon Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Brain Cancer - Pipeline Review, H2 2013

Brain Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Brain Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Nasopharyngeal Cancer - Pipeline Review, H2 2013

Nasopharyngeal Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nasopharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

Down Syndrome - Pipeline Review, H2 2013

Down Syndrome - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Down Syndrome - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Adenocarcinoma - Pipeline Review, H2 2013

Adenocarcinoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Adenocarcinoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Refractory Multiple Myeloma - Pipeline Review, H2 2013

'Refractory Multiple Myeloma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Refractory...

July 2013
FROM

Neuroblastoma - Pipeline Review, H2 2013

Neuroblastoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Neuroblastoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Rectal Cancer - Pipeline Review, H2 2013

Rectal Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Rectal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Nausea - Pipeline Review, H2 2013

Nausea - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Nausea - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

July 2013
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H2 2013

Metastatic Pancreatic Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Metastatic Pancreatic Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

July 2013
FROM

Liver Cancer - Pipeline Review, H2 2013

Liver Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Liver Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Endometrial Cancer - Pipeline Review, H2 2013

Endometrial Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Endometrial Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Small-Cell Lung Cancer - Pipeline Review, H2 2013

Small-Cell Lung Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Small-Cell Lung Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

July 2013
FROM

EpiCast Report: Pancreatic Cancer - Epidemiology Forecast to 2022

EpiCast Report: Pancreatic Cancer - Epidemiology Forecast to 2022 Summary Pancreatic cancer is one of the most fatal cancers around the world, with the highest incidence and mortality rates found...

July 2013
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)